GH Research Ownership | Who Owns GH Research?
GH Research Ownership Summary
GH Research is owned by 5.40% institutional investors, 26.78% insiders, and 67.82% retail investors. Bvf inc/il is the largest institutional shareholder, holding 14.23% of GHRS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.15% of its assets in GH Research shares.
GHRS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | GH Research | 5.40% | 26.78% | 67.82% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
| Idea | Psychedelic Stocks List | 20.20% | 9.72% | 70.08% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 8.83M | 14.23% | $126.24M |
| Lynx1 capital management lp | 8.60M | 13.87% | $104.31M |
| Ra capital management | 7.68M | 12.38% | $109.78M |
| Rtw investments, lp | 5.57M | 8.98% | $79.64M |
| Fmr | 5.33M | 8.59% | $76.18M |
| Cormorant asset management, lp | 1.92M | 3.09% | $27.41M |
| Jefferies financial group | 712.30K | 1.15% | $9.05M |
| Verition fund management | 673.74K | 1.09% | $8.56M |
| 5am venture management | 572.66K | 0.92% | $8.19M |
| Stempoint capital lp | 545.27K | 0.88% | $7.80M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lynx1 capital management lp | 8.60M | 21.23% | $104.31M |
| Bvf inc/il | 8.83M | 5.12% | $126.24M |
| 5am venture management | 572.66K | 3.00% | $8.19M |
| Cormorant asset management, lp | 1.92M | 1.89% | $27.41M |
| Stempoint capital lp | 545.27K | 1.56% | $7.80M |
| Ra capital management | 7.68M | 1.35% | $109.78M |
| Rtw investments, lp | 5.57M | 0.98% | $79.64M |
| Highvista strategies | 241.89K | 0.85% | $3.46M |
| Centerbook partners lp | 283.44K | 0.18% | $3.60M |
| Advisorshares investments | 67.11K | 0.14% | $852.32K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lynx1 capital management lp | 8.60M | 21.23% | 1.85M |
| Stempoint capital lp | 545.27K | 1.56% | 444.45K |
| Blackrock funding, inc. /de | 434.40K | 0.00% | 376.54K |
| Fmr | 5.33M | 0.00% | 234.90K |
| Highvista strategies | 241.89K | 0.85% | 189.65K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Toronto dominion bank | - | - | -1.97M |
| Deep track capital, lp | - | - | -1.25M |
| Deerfield management company, l.p. (series c) | - | - | -925.00K |
| Checkpoint capital | - | - | -185.65K |
| Ubs group | 363.38K | 0.00% | -148.08K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 169.50K | 0.00% | 169.50K | $2.42M |
| Point72 asset management | 76.96K | 0.00% | 76.96K | $1.10M |
| Bit capital gmbh | 50.00K | 0.02% | 50.00K | $635.00K |
| Tang capital management | 24.03K | 0.01% | 24.03K | $343.63K |
| Cubist systematic strategies | 22.73K | 0.00% | 22.73K | $325.07K |
Sold Out
| Holder | Change |
|---|---|
| Group one trading | -100.00 |
| Qube research | -109.00 |
| Farther finance advisors | -200.00 |
| Tortoise investment management | -1.78K |
| Adar1 capital management | -1.85K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 31 | -36.73% | 3,352,075 | -92.47% | 5 | 0.10% | 18 | -47.06% | 8 | -11.11% |
| Sep 30, 2025 | 24 | -33.33% | 15,997,108 | -63.03% | 25 | 0.46% | 19 | -9.52% | 3 | -66.67% |
| Jun 30, 2025 | 37 | 2.78% | 43,553,080 | 3.97% | 75 | 1.44% | 22 | - | 9 | 12.50% |
| Mar 31, 2025 | 38 | 18.75% | 42,619,365 | 38.84% | 73 | 2.11% | 24 | 84.62% | 7 | 16.67% |
| Dec 31, 2024 | 12 | -61.29% | 2,703,651 | -91.14% | 5 | 0.15% | 2 | -80.00% | 4 | -50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.57M | 4.15% | 2.47K |
| Fidelity Growth Compy Commingled Pl O | 1.42M | 2.74% | - |
| Fidelity Growth Company Fund | 1.56M | 2.51% | -8.78K |
| RTW Biotech Opportunities Ord | 803.70K | 1.30% | 803.70K |
| Fidelity Growth Company K6 | 536.90K | 0.87% | -5.59K |
| Fidelity Series Growth Company | 377.20K | 0.61% | -2.50K |
| iShares Biotechnology ETF | 331.60K | 0.53% | 331.60K |
| Horizons Psychedelic Stock ETF | 89.31K | 0.17% | -14.21K |
| Fidelity Select Biotechnology | 92.50K | 0.15% | - |
| AdvisorShares Psychedelics ETF | 79.33K | 0.13% | - |
GHRS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools